Edition:
United Kingdom

People: Mithra Pharmaceuticals SA (MITRA.BR)

MITRA.BR on Brussels Stock Exchange

27.58EUR
4:35pm BST
Change (% chg)

€-1.12 (-3.90%)
Prev Close
€28.70
Open
€28.72
Day's High
€28.78
Day's Low
€27.40
Volume
41,344
Avg. Vol
34,161
52-wk High
€36.95
52-wk Low
€18.12

Dillen, Michael 

Mr. Michael Dillen is CLO and Vice President - Corporate Development, Company Secretary - Representing Midico BVBA of the Company. Mr. Dillen has 10 years of experience in various legal positions, predominantly oriented towards the healthcare sector. Michaël initiated his career as a lawyer, where he developed a legal practice focused on corporate and commercial advisory towards private and institutional clients in the life sciences industry. Before joining Mithra in 2017 as Chief Legal Officer he worked for Terumo, a Japanese listed medical devices company. Here, he acted as senior counsel responsible for covering legal services in the EMEA region. Michael holds a masters degree in law, LL.M. degrees in both health law and in business law (University of Antwerp and Queen Mary and Westfield College, University of London), as well as a masters degree in business (Solvay Business School).

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --